Prerna Pharma Industries Private Limited

Prerna Pharma Industries Private Limited - pharma in Mumbai, Maharashtra, India. Directors, charges & compliance details.
CIN U24230MH1991PTC063919 Incorporated 06 November 1991 ROC Mumbai HQ Mumbai, Maharashtra, India
Converted to LLP Private Limited Company pharma
Revenue · FY 2018
₹40.37 Lakh
▲ 9% YoY
Net profit · FY 2018
₹13.84 Lakh
Net margin 34.3%
EBITDA · FY 2018
₹18.02 Lakh
EBITDA margin 44.6%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.49 Cr
Issued & subscribed
Satisfied charges
₹1.92 Cr
No open charges
Company age
35 yrs
Est. 1991
Active GSTINs
1
of 3 registered

About Prerna Pharma Industries Private Limited

Data last updated:

Prerna Pharma Industries Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 November 1991.

The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1991PTC063919. Its GSTIN is 27AABCP9536G2Z6 (Maharashtra). The company held 3 GST registrations, of which 1 is active.

The company had an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.49 Cr. It was formerly known as Prerna Pharma Intermediates Pvt Ltd.

Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at 501 Sentinel 5th Floor Hiranandani Gardens Central Avenue Road Powai, Mumbai, Maharashtra, India – 400076.

As per the financials filed for FY 2018, the company reported a revenue of ₹40.37 Lakh, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹13.84 Lakh (net margin 34.3%) and EBITDA of ₹18.02 Lakh (EBITDA margin 44.6%). Revenue has declined at a compounded annual rate (CAGR) of 32% over three years.

As per MCA filings, the company has satisfied charges of ₹1.92 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.

Company details

CIN U24230MH1991PTC063919
Registration Number 063919
Incorporation Date 06 November 1991
ROC Mumbai
Listing Status Unlisted
Company Status Converted to LLP

Contact details

Prerna Pharma Industries Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.

  • Email
  • Registered Address
    501 Sentinel 5th Floor Hiranandani Gardens Central Avenue Road Powai, Mumbai, Maharashtra, India – 400076
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Prerna Pharma Industries Private Limited, buy the company report.

Comprehensive company report
Prerna Pharma Industries Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Prerna Pharma Industries is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

Financials of Prerna Pharma Industries Private Limited

FY 2018 filings available

Prerna Pharma Industries Private Limited reported revenue of ₹40.37 Lakh (up 9% YoY) for FY 2018.

Revenue · FY 2018
₹40.37 Lakh ▲ 9%
Net profit · FY 2018
₹13.84 Lakh margin 34.3%
EBITDA · FY 2018
₹18.02 Lakh margin 44.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 9%
3 years · compounded
▼ 32%
EBITDA CAGR growth
1 year
▲ 90%
3 years · compounded
▼ 21%

Revenue rose 9% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 32%. EBITDA rose 90% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹40.37 Lakh
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹18.02 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹13.84 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profitability
EBITDA Margin44.6%
Net Profit Margin34.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Prerna Pharma Industries Private Limited, buy the company report.

Board of directors of Prerna Pharma Industries Private Limited

Prerna Pharma Industries has 3 former directors on record and no current directors listed.

Auditor

Prerna Pharma Industries Private Limited is audited by BIMAL R MEHTA & ASSOCIATES for the financial year 2018.

Auditor firmFinancial yearFirm registration number
BIMAL R MEHTA & ASSOCIATESFY 2018114268W

Shareholding

The shareholding of Prerna Pharma Industries Private Limited is on record for 4 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2018FY 2017FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Prerna Pharma Industries Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹1.92 Cr
Breakdown by lending institutions
Canara Bank₹1.62 Cr
Sicom Housing Development Finance Ltd₹0.20 Cr
State Bank of India₹0.10 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
07 Jul 200490145272Canara Bank₹87 LakhSatisfied
07 Mar 200390144373Canara Bank₹75 LakhSatisfied
29 Nov 200190140969Sicom Housing Development Finance Ltd₹20 LakhSatisfied
19 Oct 199490147035State Bank of India₹10 LakhSatisfied

To see the full charge records of Prerna Pharma Industries Private Limited, buy the company report.

Total charge records: 4 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Prerna Pharma Industries Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Prerna Pharma Industries has 3 GST registrations: 1 active and 2 cancelled or inactive.

Total GSTINs
3
Active
1
Cancelled / inactive
2
GSTINStateStatusRegistered on
27AABCP9536G2Z6MaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Prerna Pharma Industries Private Limited, buy the company report.

Recent activity

Prerna Pharma Industries Private Limited has 3 board changes on record since 2009: 0 appointments and 3 cessations. The latest: Devesh Malladi ceased to be Director on 28 Mar 2019.

Ceased
Devesh Malladi ceased to be Director.
Ceased
Vishwanath Jonnalagadda ceased to be Director.
AGM
Prerna Pharma Industries Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records.
Filing
Prerna Pharma Industries Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Mumbai.
Charges
A charge registered on 07 Mar 2003 via Charge ID 90144373 with Canara Bank was fully satisfied on 19 May 2012.
Charges
A charge registered on 07 Jul 2004 via Charge ID 90145272 with Canara Bank was fully satisfied on 20 Aug 2009.
Ceased
Surendralal Uppal ceased to be Director.
Charges
A charge with Canara Bank amounted to Rs. 0.87 Cr with Charge ID 90145272 was registered on 07 Jul 2004.
Charges
A charge with Canara Bank of Rs. 0.75 Cr registered on 07 Mar 2003 with Charge ID 90144373 was modified on 27 Mar 2003.
Charges
A charge with Canara Bank amounted to Rs. 0.75 Cr with Charge ID 90144373 was registered on 07 Mar 2003.
Charges
A charge registered on 29 Nov 2001 via Charge ID 90140969 with Sicom Housing Development Finance Ltd was fully satisfied on 28 Feb 2003.
Charges
A charge with Sicom Housing Development Finance Ltd amounted to Rs. 0.20 Cr with Charge ID 90140969 was registered on 29 Nov 2001.

4 earlier events are in the company report.

Frequently asked questions

Prerna Pharma Industries has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.

Prerna Pharma Industries was a private limited company based in Mumbai, Maharashtra, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 06 November 1991 and is registered under CIN U24230MH1991PTC063919. For the latest details, refer to the successor LLP entity.

The CIN (Corporate Identification Number) of Prerna Pharma Industries is U24230MH1991PTC063919. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Prerna Pharma Industries was incorporated on 06 November 1991. It is registered with the Registrar of Companies, Mumbai.

The registered office of Prerna Pharma Industries is at 501 Sentinel 5th Floor Hiranandani Gardens Central Avenue Road Powai, Mumbai, Maharashtra, India – 400076.

The latest financial statements of Prerna Pharma Industries on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from 2015 are in the company report.

The GSTIN of Prerna Pharma Industries is 27AABCP9536G2Z6, registered in Maharashtra. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.

Prerna Pharma Industries operated in the pharma industry, in the drug formulation and development segment.

Prerna Pharma Industries has 1 court case on record: 1 filed by the company.

Devesh Malladi ceased to be Director on 28 Mar 2019. Vishwanath Jonnalagadda ceased to be Director on 28 Mar 2019. Surendralal Uppal ceased to be Director on 27 Apr 2009.